Melissa S Putman1, Tregony Simoneau2, Henry A Feldman3, Alexandra Haagensen4, Debra Boyer5. 1. Division of Endocrinology, Boston Children's Hospital, Boston, MA, United States; Endocrine Unit, Massachusetts General Hospital, Boston, MA, United States. Electronic address: melissa.putman@childrens.harvard.edu. 2. Department of Pulmonary Medicine, Connecticut Children's Medical Center, Hartford, CT, United States. 3. Clinical Research Center, Boston Children's Hospital, Boston, MA, United States. 4. Division of Endocrinology, Boston Children's Hospital, Boston, MA, United States. 5. Division of Respiratory Diseases, Boston Children's Hospital, Boston, MA, United States.
Abstract
INTRODUCTION: Children undergoing lung transplant are at risk for low bone mineral density (BMD) and fractures. The effect of lung transplantation on bone health in pediatric patients is unknown. MATERIALS AND METHODS: We performed a retrospective chart review of all patients ages 2-21 years who underwent lung transplantation at our hospital from January 2000 to January 2015. RESULTS: 51 patients were studied. At the time of transplant evaluation, BMD Z-score was -2.2 ± 1.4, and 59% of patients had low BMD. BMD Z-score declined in the first year after treatment and returned to near-baseline by the third post-transplant year. Fractures occurred in 9 patients (18%) before and 15 patients (29%) after transplant. Bisphosphonate use was associated with improvement in BMD Z-score and lower mortality risk. CONCLUSIONS: Pediatric patients had a high prevalence of low BMD at the time of lung transplant evaluation. BMD Z-scores declined in the year after transplant and returned to the pre-transplant level by the third post-transplant year while remaining below normal levels. Fractures were common at sites associated with significant morbidity. These findings support efforts to optimize bone health before and after pediatric lung transplantation, and future studies are needed to evaluate the role of bisphosphonates in these patients.
INTRODUCTION:Children undergoing lung transplant are at risk for low bone mineral density (BMD) and fractures. The effect of lung transplantation on bone health in pediatric patients is unknown. MATERIALS AND METHODS: We performed a retrospective chart review of all patients ages 2-21 years who underwent lung transplantation at our hospital from January 2000 to January 2015. RESULTS: 51 patients were studied. At the time of transplant evaluation, BMD Z-score was -2.2 ± 1.4, and 59% of patients had low BMD. BMD Z-score declined in the first year after treatment and returned to near-baseline by the third post-transplant year. Fractures occurred in 9 patients (18%) before and 15 patients (29%) after transplant. Bisphosphonate use was associated with improvement in BMD Z-score and lower mortality risk. CONCLUSIONS: Pediatric patients had a high prevalence of low BMD at the time of lung transplant evaluation. BMD Z-scores declined in the year after transplant and returned to the pre-transplant level by the third post-transplant year while remaining below normal levels. Fractures were common at sites associated with significant morbidity. These findings support efforts to optimize bone health before and after pediatric lung transplantation, and future studies are needed to evaluate the role of bisphosphonates in these patients.
Authors: Celia Rodd; Bianca Lang; Timothy Ramsay; Nathalie Alos; Adam M Huber; David A Cabral; Rosie Scuccimarri; Paivi M Miettunen; Johannes Roth; Stephanie A Atkinson; Robert Couch; Elizabeth A Cummings; Peter B Dent; Janet Ellsworth; John Hay; Kristin Houghton; Roman Jurencak; Maggie Larché; Claire LeBlanc; Kiem Oen; Claire Saint-Cyr; Robert Stein; David Stephure; Shayne Taback; Brian Lentle; Maryann Matzinger; Nazih Shenouda; David Moher; Frank Rauch; Kerry Siminoski; Leanne M Ward Journal: Arthritis Care Res (Hoboken) Date: 2012-01 Impact factor: 4.794
Authors: G S Reusz; A J Szabó; F Péter; E Kenesei; P Sallay; K Latta; A Szabó; A Szabó; T Tulassay Journal: Arch Dis Child Date: 2000-08 Impact factor: 3.791
Authors: E Shane; M Rivas; D J McMahon; R B Staron; S J Silverberg; M J Seibel; D Mancini; R E Michler; K Aaronson; V Addesso; S H Lo Journal: J Clin Endocrinol Metab Date: 1997-05 Impact factor: 5.958
Authors: J Feber; P Cochat; P Braillon; F Castelo; X Martin; C Glastre; F Chapuis; L David; P J Meunier Journal: J Pediatr Date: 1994-12 Impact factor: 4.406
Authors: Oliver Tschopp; Annette Boehler; Rudolf Speich; Walter Weder; Burkhardt Seifert; Erich W Russi; Christoph Schmid Journal: Am J Transplant Date: 2002-02 Impact factor: 8.086